Outcomes in diabetics undergoing revascularization: the long and the short of it.

[1]  Jeffrey L Carson,et al.  Diabetes mellitus increases short-term mortality and morbidity in patients undergoing coronary artery bypass graft surgery. , 2002, Journal of the American College of Cardiology.

[2]  C. Bauters,et al.  Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. , 2002, Journal of the American College of Cardiology.

[3]  Karel G M Moons,et al.  Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery: a randomized trial. , 2002, JAMA.

[4]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[5]  R. Califf,et al.  Differential Influence of Diabetes Mellitus on Increased Jeopardized Myocardium After Initial Angioplasty or Bypass Surgery: Bypass Angioplasty Revascularization Investigation , 2002, Circulation.

[6]  J. Carson.  Diabetes melitus increase short-term mortality and morbidity in patients undergoing CABG , 2002 .

[7]  Benno J. Rensing,et al.  Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up , 2001, Circulation.

[8]  C. Cernigliaro.  [Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[9]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[10]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[11]  D. Wennberg,et al.  Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. , 2001, Journal of the American College of Cardiology.

[12]  C. Bauters,et al.  Patency of Percutaneous Transluminal Coronary Angioplasty Sites at 6-Month Angiographic Follow-Up: A Key Determinant of Survival in Diabetics After Coronary Balloon Angioplasty , 2001, Circulation.

[13]  M. Gotsman,et al.  Restenosis and Progression of Coronary Disease after Balloon Angioplasty in Patients with Diabetes Mellitus , 2000, Clinical cardiology.

[14]  Deepak L. Bhatt,et al.  Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy. , 1999, Circulation.

[15]  F. Ragmin.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999, The Lancet.

[16]  C. Bauters,et al.  Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients. , 1999, Journal of the American College of Cardiology.

[17]  E. Jones,et al.  Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting. , 1999, The Annals of thoracic surgery.

[18]  R. Califf,et al.  Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). , 1999, Circulation.

[19]  I. Angin.  Sulfonylurea Drugs Increase Early Mortality in Patients with Diabetes Mellitus after Direct Angioplasty for Acute Myocardial Infarction , 1999 .

[20]  L. Wallentin,et al.  Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study , 1999 .

[21]  R. Califf,et al.  Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). , 1999, Circulation.

[22]  M. Hadamitzky,et al.  Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. , 1998, Journal of the American College of Cardiology.

[23]  M. Leon,et al.  The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. , 1998, Journal of the American College of Cardiology.

[24]  David P Miller,et al.  Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators. , 1998, Circulation.

[25]  M. Gotsman,et al.  Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. , 1997, Journal of the American College of Cardiology.

[26]  R. Califf,et al.  Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. , 1997, Circulation.

[27]  T. B. Investigators,et al.  Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) , 1997, Circulation.

[28]  C. Bauters,et al.  Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. , 1997, Circulation.

[29]  M. Leon,et al.  Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study. , 1997, Circulation.

[30]  R. Califf,et al.  Impact of Diabetes Mellitus on Percutaneous Revascularization (CAVEAT-I) , 1997 .

[31]  D. Faxon,et al.  Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. , 1996, The Journal of clinical investigation.

[32]  J. Herlitz,et al.  Mortality and Morbidity in Diabetic and Nondiabetic Patients During a 2-Year Period After Coronary Artery Bypass Grafting , 1996, Diabetes Care.

[33]  Z. Bloomgarden,et al.  Potential mechanisms promoting restenosis in diabetic patients. , 1996, Journal of the American College of Cardiology.

[34]  S. Nitter‐Hauge,et al.  Diabetes mellitus and morbidity and mortality risks after coronary artery bypass surgery. , 1996, Scandinavian journal of thoracic and cardiovascular surgery.

[35]  W. Weintraub,et al.  Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. , 1995, Circulation.

[36]  R. Fietsam,et al.  Complications of coronary artery surgery in diabetic patients. , 1991, The American surgeon.

[37]  G. Lawrie,et al.  Influence of diabetes mellitus on the results of coronary bypass surgery. Follow-up of 212 diabetic patients ten to 15 years after surgery. , 1986, JAMA.

[38]  H. Beck-Nielsen,et al.  Prevalence and Mortality of Acute Myocardial Infarction in Patients with Diabetes , 1985, Diabetes Care.

[39]  J. Okies,et al.  Diabetes mellitus and coronary artery bypass. Short-term risk and long-term prognosis. , 1983, The Journal of thoracic and cardiovascular surgery.